Translational Development Acquisition Corp. (TDACU) Cash from Operations (2024 - 2026)

Translational Development Acquisition (TDACU) has 3 years of Cash from Operations data on file, last reported at 305157.0 in Q1 2026.

• Quarterly Cash from Operations fell 31.78% year-over-year to 305157.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 681970.0 (changed N/A YoY) and the FY2025 annual result came in at 608387.0, up 28.55% from the prior year.
• Cash from Operations slipped to 305157.0 in Q1 2026, from 117363.0 in the prior quarter.
• In the past five years, Cash from Operations ranged from a high of 88105.0 in Q3 2025 to a low of 810963.0 in Q4 2024.
• A 3-year average of 287417.83 and a median of 201459.5 in 2025 frame the typical range for Cash from Operations.
• Annual changes were most pronounced in 2025 — Cash from Operations jumped 85.53% — and 2026, when it slumped 31.78%.
• Tracing TDACU's Cash from Operations over 3 years: stood at 810963.0 in 2024, then jumped by 85.53% to 117363.0 in 2025, then tumbled by 160.01% to 305157.0 in 2026.
• The last three Cash from Operations figures came in at 305157.0 (Q1 2026), 117363.0 (Q4 2025), and 88105.0 (Q3 2025), per Business Quant data.